Back to Selection     Print       Date : 30 Nov 2025
Fund Summary
Tata India Pharma & HealthCare Fund Reg Plan (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 28-Dec-15
Corpus(Cr.) 1339.0 Latest NAV 28.2475 As on 29-01-2026
Equity(%) 95.0 52 Week High 31.3901
Debt(%) 5.0 52 Week Low 26.5729
Others(%) 0.0 Exit Load 0.25% for redemption within 30 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 2.10
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Rajat Srivastava
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 28.42%
Top 10 Holdings 47.17%
Top 25 Holdings 88.30%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 55.19
Healthcare 35.67
Cash 5.0
Fertilisers 4.14
 
 
 
 
 
Portfolio Metrics
PB Ratio 6.60
PE Ratio 0.00
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 7.75
Max Healthcare Institute Limited 5.65
Healthcare Global Enterprises Limited 5.13
Abbott India Limited 5.04
Apollo Hospitals Enterprise Limited 4.85
IPCA Laboratories Limited 3.99
Cipla Limited 3.96
RAINBOW CHILDRENS MEDICARE LIMITED 3.78
Lupin Limited 3.57
Ajanta Pharma Limited 3.45
J B Chemicals and Pharma Ltd 3.36
Bayer Crop Science Ltd 3.23
DIVI LABORATORIES LTD. 3.10
Metropolis Healthcare Limited 3.08
Torrent Pharmaceuticals Limited 3.00
Mankind Pharma Limited 2.95
FDC Limited 2.87
Alkem Laboratories Limited 2.85
Krishna Inst of Medical Sciences Ltd. 2.84
Dr Lal Path Labs Ltd 2.61
CASH / NET CURRENT ASSET 2.61
REPO 2.39
Syngene International Limited 2.35
Sai Life Sciences Limited 1.99
Cohance Lifesciences Limited 1.90

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-5.54% -9.15% -9.54% -2.12%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
-1.95% -2.33% 2.82% 11.06%
 
Scheme Benchmark [NSE - Nifty Pharma]
-4.33% -3.86% -6.54% 1.89%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
9.26% 19.87% 14.27% 10.81%
 
 
9.44% 14.31% 14.62% 14.28%
 
 
10.60% 19.85% 12.11% 6.25%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Tata India Pharma & HealthCare Fund Reg Plan (G) 16.04% 1.0635 10.4494% 44.9256 0.1482
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Tata India Pharma & HealthCare Fund Reg Plan (G) 11.6069% 0.0002 0.2852 14.2979 0.6982
 
Back to Selection